# Inhibrx Biosciences, Inc.: Form SC 13D, filed Jun 3, 2024

- Company: [Inhibrx Biosciences, Inc.](/companies/inbx.md) (CIK 2007919)
- Form: SC 13D
- Filed: 2024-06-03
- Accepted by EDGAR: Jun 4, 2024, 00:43 ET
- Period: not reported
- Accession: 0000950142-24-001548
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2007919/000095014224001548/eh240491006_13d-lappe.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2007919/000095014224001548/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2007919/000095014224001548/eh240491006_13d-lappe.htm

Filed Jun 3, 2024.
Source: SEC EDGAR, the filing index for accession 0000950142-24-001548. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.